Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 25,058 shares at $20.14 ($500K) on 2019-03-01, disclosed to the SEC on 2019-03-04.
Open-market sale of $500k VNDA by SVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.14 | 3,741 | $75K | 15.1% |
| 2 | $20.14 | 3,741 | $75K | 15.1% |
| 3 | $19.89 | 8,788 | $175K | 34.9% |
| 4 | $19.89 | 8,788 | $175K | 34.9% |
| Total | $19.96 avg | 25,058 | $500K | 100% |
| Filing → |
| VNDA | SELL | 2023-03-06 | $209K | — | Filing → |
| VNDA | SELL | 2022-03-02 | $305K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $748K | — | Filing → |